Loading clinical trials...
Loading clinical trials...
Prospective Regional Epilepsy Database and Biobank for Individualized Clinical Treatment
PREDICT is an observational study following adults with an unprovoked seizure or epilepsy in the health care region of western Sweden. The objective is to identify biomarkers and/or genetic predisposition of relevance for diagnosis and/or treatment of epilepsy and study the long-term prognosis and consequences of epilepsy.
Adults over 18 years of age, with an unprovoked seizure in the last year or epilepsy, resident in the health care region of western Sweden (VGR) at the time of inclusion. Baseline data and outcome variables are collected from several patient registries: the electronic medical records system in the health care region VGR and Swedish National Registers of healthcare, income, and employment managed by The National Board of Health and Welfare or Statistics Sweden, both of which are government agencies.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Södra Älvsborgs Sjukhus
Borås, Sweden
Sahlgrenska University Hospital
Gothenburg, Sweden
Sjukhusen i Väster
Gothenburg, Sweden
Start Date
November 27, 2020
Primary Completion Date
December 31, 2031
Completion Date
December 31, 2031
Last Updated
June 13, 2025
1,000
ESTIMATED participants
Seizure status
OTHER
Tests
DIAGNOSTIC_TEST
Epilepsy
OTHER
Demographics and psychosocial
OTHER
Health care
OTHER
Lead Sponsor
Sahlgrenska University Hospital
NCT06700356
NCT02531880
NCT05871372
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions